GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » EPS without NRI

iAnthus Capital Holdings (iAnthus Capital Holdings) EPS without NRI : $-0.01 (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings EPS without NRI?

iAnthus Capital Holdings's earnings per share without non-recurring items for the three months ended in Mar. 2024 was $-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 78.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 59.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for iAnthus Capital Holdings's EPS without NRI or its related term are showing as below:

ITHUF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -118.6   Med: -5.15   Max: 78.2
Current: 78.2

During the past 9 years, iAnthus Capital Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 78.20% per year. The lowest was -118.60% per year. And the median was -5.15% per year.

ITHUF's 3-Year EPS without NRI Growth Rate is ranked better than
95.6% of 840 companies
in the Drug Manufacturers industry
Industry Median: 9.8 vs ITHUF: 78.20

iAnthus Capital Holdings's EPS (Diluted) for the three months ended in Mar. 2024 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.

iAnthus Capital Holdings's EPS (Basic) for the three months ended in Mar. 2024 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.


iAnthus Capital Holdings EPS without NRI Historical Data

The historical data trend for iAnthus Capital Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings EPS without NRI Chart

iAnthus Capital Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -0.70 -0.98 -0.42 -0.05 -0.01

iAnthus Capital Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of iAnthus Capital Holdings's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's PE Ratio without NRI falls into.



iAnthus Capital Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iAnthus Capital Holdings  (OTCPK:ITHUF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


iAnthus Capital Holdings EPS without NRI Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Proud Richard C. Jr. director, officer: CEO and Director 8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi director SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson director 2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc 10 percent owner 1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert director C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin officer: Interim CEO and COO
Senvest Management, Llc director, 10 percent owner, other: (See Remarks) 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin director ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd. 10 percent owner UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer 10 percent owner C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3